menu search

Down 24% in a month, will arvinas stock rebound?

The stock price of Arvinas (NASDAQ: ARVN), a biopharmaceuticals company focused on oncology treatments ...

June 2, 2022, 6:00 am

Catalent, inc. to present at june investor conferences

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, ...

May 27, 2022, 8:26 am

Cancer treatments may benefit from lessons of pandemic set-backs -astrazeneca executive

Although cancer screening and diagnosis was hit by the coronavirus pandemic, resulting advances in medical technology and greater diversity in clinica...

May 26, 2022, 1:07 pm

Diamedica therapeutics to attend the 19th annual craig-hallum institutional investor conference wednesday, june 1, 2022

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel ...

May 25, 2022, 4:15 pm

Correction: sensus healthcare to participate in the h.c. wainwright global investment conference

BOCA RATON, Fla, May 23, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, n...

May 23, 2022, 3:56 pm

Why kala pharmaceuticals shares are rising today

Kala Pharmaceuticals Inc (NASDAQ: KALA) shares are trading higher after the company said it would sell its EYSUVIS and INVELTYS ...

May 23, 2022, 10:17 am

Regeneron: bright future ahead

Regeneron has a very strong pipeline consisting of treatments that can complement current cash cows (EY...

May 23, 2022, 3:55 am

7 cheap biotech stocks to buy now

These biotech stocks are speculative, but could potentially blow up in the next couple of years with new treat...

May 19, 2022, 6:00 pm

Braxia scientific to present at h.c. wainwright global investment conference, miami from may 24-26, 2022

TORONTO , May 19, 2022 /PRNewswire/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research c...

May 19, 2022, 5:50 pm

Avalon globocare to team up with lu daopei hematology institute to develop companion diagnostics for car-t cancer treatments

Avalon GloboCare Corp (NASDAQ:AVCO) has signed a memorandum of understanding with Lu Daopei Hematology Institute (LDHI) to co-develop precision compan...

May 18, 2022, 10:53 am

Here's the no. 1 reason to buy vertex pharmaceuticals now

The company's current treatments dominate the cystic fibrosis market, but it's the pipeline that makes ...

May 14, 2022, 6:30 am

Novocure can recover on its long-term outlook

NovoCure's growth has stalled as their GBM market share has gone to 35%-40%, but GBM still offers several additional growth opportunities. Then there ...

May 10, 2022, 8:45 am

Predictive oncology has an ai-driven drug discovery platform to improve cancer treatments and speed up drug development

Predictive Oncology IncĀ is blazing a path as a company that can operate through the fullness of the R&D spectrum of pharma and speed up new cancer ...

May 10, 2022, 7:02 am

Why gsk may have bet too big on a pandemic pipeline

Its late-stage pipeline is heavily weighted toward pandemic treatments....

May 7, 2022, 7:57 am

Earnings results: davita stock falls as higher wages, missed treatments push earnings below street expectations

DaVita Inc. shares dropped in the extended session Thursday after the dialysis-service provider's earnings fell short of Wall Street estimates as the ...

May 5, 2022, 6:18 pm

Amazon announces benefit to pay for us employees who travel for abortions, other treatments

Online retail giant Amazon.com took a firm stance Monday pushing against a prevailing Republican-led push to restrict access to abortion, telling its ...

May 4, 2022, 1:20 pm

Alpine immune sciences announces participation in may investor conferences

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...

May 3, 2022, 8:05 am

Vera therapeutics selected to present interim phase 2 data for mau868 to treat bk virus in kidney transplant patients as oral late-breaker at the american transplant congress 2022

BRISBANE, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing an...

May 2, 2022, 7:06 pm

Novo nordisk lifts 2022 outlook after strong quarter, shares jump

Shares in Novo Nordisk jumped on Friday after the firm lifted its sales and operating profit guidance for the year on the back of forecast-beating fir...

April 29, 2022, 3:27 am

Pfizer asks fda to authorize covid booster for kids 5-11

As the omicron variant puts children at greater risk of hospitalization, public health officials have worked to make Covid-19 ...

April 26, 2022, 6:52 pm


Search within

Pages Search Results: